(Q34292013)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423259%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

review article

1 reference

title

Pathogenetic and histogenetic features of HIV-associated Hodgkin's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423259%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423259%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Annunziata Gloghini

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423259%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Antonino Carbone

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423259%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

M Boiocchi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423259%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 July 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423259%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423259%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423259%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423259%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

1276-1287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423259%20AND%20SRC:MED&resulttype=core&format=json

Epidemiologic patterns of Hodgkin's Disease

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

International patterns in the occurrence of Hodgkin's disease in children and young adult males

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Cancer among New York men at risk of acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Increased Incidence of Hodgkin Disease in Homosexual Men with HIV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco, 1980-1987.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978-1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Spectrum of AIDS-associated malignant disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Risk of cancer in people with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Cancer risk among men with, or at risk of, HIV infection in southern Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

HIV-associated malignant lymphomas in Kenya (Equatorial Africa)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Aids and cancer in Africa: the evolving epidemic in Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Hodgkin's disease during HIV1 infection: the French registry experience. French Registry of HIV-associated Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Hodgkin's disease in HIV-infected intravenous drug abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Malignant lymphomas in a population at risk for acquired immune deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Incidence of Lymphomas and Other Cancers in HIV-Infected and HIV-Uninfected Patients With Hemophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Hodgkin's disease: old and recent clinical concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

The CD40 antigen and its ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Hodgkin's disease in 92 patients with HIV infection: The Italian experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Clinical aspects and management of Hodgkin's disease and other tumours in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Epstein-Barr virus in the pathogenesis of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Hodgkin's disease and the Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Neoplastic cells of Hodgkin's disease show differences in EBV expression between Kenya and Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

IDENTIFICATION OF EBV-DNA IN TUMOUR CELLS OF AIDS-RELATED LYMPHOMAS BY IN-SITU HYBRIDISATION

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

High incidence of monoclonal EBV episomes in Hodgkin's disease and anaplastic large-cell ki-1-positive lymphomas in HIV-1-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

The expression and function of Epstein-Barr virus encoded latent genes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Pathological, Immunological, and Molecular Features of Hodgkin's Disease Associated with HIV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

The oncogenic potential of Epstein-Barr virus nuclear antigen 1 in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

AP-1: one switch for many signals

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Jaks and STATs: biological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Direct immunosuppressive effects of EBV-encoded latent membrane protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Viral involvement in Hodgkin's disease: detection of clonal type A Epstein-Barr virus genomes in tumour samples

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Subtypes of Epstein-Barr virus in HIV-1-associated and HIV-1-unrelated Hodgkin's disease cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Hodgkin's disease in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Primary Hodgkin's lymphoma: an unusual cause of graft dysfunction after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Epstein-Barr virus-associated Hodgkin's disease following renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Epstein-Barr virus-associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900105-8

7 January 2021

10.1016/S0959-8049(01)00105-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423259%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference